טוען...
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor
Nerve growth factor is a therapeutic candidate for Alzheimer’s disease. Due to its pain-inducing activity, in current clinical trials nerve growth factor is delivered locally into the brain by neurosurgery, but data on the efficacy of local nerve growth factor delivery in decreasing amyloid-β deposi...
שמור ב:
| הוצא לאור ב: | Brain |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5379860/ https://ncbi.nlm.nih.gov/pubmed/28031222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/aww271 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|